Breakthrough pill Gepotidacin offers new hope against drug-resistant gonorrhea
The trial found gepotidacin cured 92.6% of participants, matching current standard treatments.
Intracellular gonorrhea bacteria seen in gram staining under a microscope.(photo credit: Rextta. Via Shutterstock)